Neutralising antibodies in patients with multiple myeloma receiving maintenance therapy with interferon alpha 2b.

Bell, J B; Barfoot, R; Iveson, T; Powles, R L; Millar, B C

Bell, J B; Barfoot, R; Iveson, T; Powles, R L; Millar, B C.

Affiliation

Bell JB; McElwain Laboratories, Institute of Cancer Research, Sutton, Surrey, UK.

Br J Cancer ; 70(4): 646-51, 1994 Oct.

Article in En | MEDLINE | ID: mdl-7917911

Subject(s)

Antibodies, Neoplasm/blood; Interferon-alpha/immunology; Interferon-alpha/therapeutic use; Multiple Myeloma/immunology; Multiple Myeloma/therapy; Antibodies, Neoplasm/immunology; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Autoantibodies/blood; Enzyme-Linked Immunosorbent Assay; HeLa Cells; Humans; Interferon alpha-2; Interferon-alpha/blood; Leukocytes/immunology; Leukocytes/metabolism; Multiple Myeloma/blood; Neutralization Tests; Recombinant Proteins

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Interferon-alpha / Antibodies, Neoplasm / Multiple Myeloma Limits: Humans Language: En Journal: Br J Cancer Year: 1994 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google